MiR-21-5p and miR-22-3p, both upregulated in COVID-19 patients, target several genes involved in cell signaling, cell proliferation and angiogenesis (e.g., HIF1A, MYC, SP1, SMAD7, VHL). The gene discussed is VHL; the disease is COVID-19.